Ohio Attorney General Dave Yost announced that he along with 21 other attorneys general have secured final approval of a combined $17.3 billion settlement to hold two drug makers and two pharmacies accountable for their roles in the opioid-addiction crisis and help fund opioid recovery efforts.
Under the settlement, Ohio expects to receive a total of $679.6 million from drug makers Teva and Allergan and pharmacies CVS and Walgreens over the next 15 years.
The state of Georgia has signed on to a $3.1 billion national agreement with Walmart amid allegations that the retailer didn’t properly monitor opioids dispensing at its pharmacies; Georgia is expected to get $28 million in the deal, according to an announcement from Attorney General Chris Carr.
“The opioid epidemic has destroyed lives, families, and communities all across our state and nation,” Carr said in the release.
Virginia is expected to receive $60 million as part of a tentative $3.1 billion settlement agreement with Walmart after allegations of insufficient oversight of opioid dispensing at the chain’s pharmacies.
“Companies who facilitated the dispensing of opioids contributed to the opioid epidemic that has devastated millions of lives. This significant settlement will help us fight back against the epidemic and provide abatement and rehabilitation resources to suffering Virginians,” Attorney General Jason Miyares said in a press release.
Ohio Attorney General Dave Yost (R) announced on Tuesday that he and 15 other state attorneys general have negotiated a preliminary deal with the multinational retailer Walmart, from which Ohio would get $114 million for opioid recovery programs.
The $3.1 billion national agreement comes after Yost and other prosecutors sought accountability for what they characterize as the superstore’s failure to safely and securely dispense high-strength prescription pain relievers through its more than 5,100 pharmacies across America. Other state prosecutor’s offices who worked alongside him include California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Louisiana, Massachusetts, North Carolina, Nebraska, Pennsylvania, New York, Tennessee and Texas.
The agreement comes after Yost and other prosecutors sought accountability for what they characterize as the superstore’s failure to safely and securely dispense high-strength prescription pain relievers through its more than 5,100 pharmacies across America. Other state prosecutor’s offices who worked alongside him include California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Louisiana, Massachusetts, North Carolina, Nebraska, Pennsylvania, New York, Tennessee and Texas.
Virginia localities have begun receiving payments from an opioid-related settlement with three distributors, which are separate from the state funding and total more than $4 million in the first installment.
McKesson, AmerisourceBergen and Cardinal Health agreed to pay the commonwealth and its localities about $530 million for allegedly being involved in higher overdose rates. Virginia will receive about $15 million and the Opioid Abatement Authority will receive more than $9.9 million in the first installment, in addition to the $4 million heading to localities.
Arizona Attorney General Mark Brnovich (R) recently announced two historic multistate settlements, totaling $26 billion, with four pharmaceutical companies over their roles in the opioid crisis.
“We are working to get these opioid abatement funds to local communities as quickly as possible,” Brnovich said in a press release. “They will help facilitate more effective treatment, education, and prevention as our state continues to tackle this heartbreaking crisis.”
Michigan could receive up to nearly $800 million from a proposed multibillion-dollar national opioid settlement with Johnson & Johnson and the three largest pharmaceutical distributors in the country: Cardinal Health, McKesson, and AmerisourceBergen.
Michigan Attorney General Dana Nessel officially signed the agreement announced last month for the companies role in the opioid epidemic.
Governor Ron DeSantis praised a multi-state agreement between three of the largest pharmaceutical companies in the nation, AmerisourceBergen, Cardinal Health, and McKesson, worth $21 billion.
DeSantis also praised a separate agreement by Johnson and Johnson who will pay $5 billion over the next nine years. The agreements will aim to settle litigation regarding the opioid crisis in not only Florida, but the nation as a whole.
by Tim Pearce Ten international corporations contacted by The Daily Caller News Foundation got their start in the U.S. but stayed silent when asked if they saw themselves as “American” companies. Nine others responded to TheDCNF’s inquiry by either identifying with their American heritage, obscuring their loyalties or declining to comment…